A recent study has reported potentiation of 177Lu-octreotate PRRT by PARPi in a rat pancreatic adenocarcinoma cell line that endogenously expresses SSTR2, and in the human osteosarcoma cell line U2OS that was modified to express exogenous SSTR2 [23]. The gene discussed is SSTR2; the disease is osteosarcoma.